Product Name: Human CSF2 / GM-CSF Antibody (Theraclone patent anti-GM-CSF, Research Use)
Catalog Number: NBR-0891
Target Name: CSF2 / GM-CSF
Trade Name: Theraclone patent anti-GM-CSF
Antibody Drug Description: The drug is a recombinant fully human anti-GM-CSF monoclonal antibody, being developed by Theraclone. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CSF2
Synonyms: GMCSF; Sargramostim; GM-CSF
Target Description: CSF2 (Colony Stimulating Factor 2) is a Protein Coding gene. Diseases associated with CSF2 include Pulmonary Alveolar Proteinosis and Mucositis. Among its related pathways are MIF Mediated Glucocorticoid Regulation and Gene expression (Transcription). Gene Ontology (GO) annotations related to this gene include cytokine activity and granulocyte macrophage colony-stimulating factor receptor binding.
Ensembl: ENSG00000164400
Uniprot: P04141